You are here
- Home
- Therapy Areas
- Neuroscience
An open-label prospective study to investigate the safety, efficacy and tolerability of quetiapine in adolescents and adults experiencing their first psychotic episode in and Australian Health Care Setting.
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- Aug 27, 2003
- Study Name
- AU-SEA-0005
- Study Id
- AU-SEA-0005
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
